A novel risk-stratification model that predicts long-term clinical outcomes in patients with recurrent pericarditis

30 August 2024 (08:00 - 17:30)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Ashwin Kumar

Georgetown University, Washington, DC (United States of America)

9 More presentations in this session

Presentation thumbnail

Whole exome sequencing in patients with recurrent pericarditis

Doctor V. Collini (Udine, IT)

Abstract Slides Video

Presentation thumbnail

Prognostic factors and etiological insights in constrictive pericarditis

Doctor L. Admella Severiano (Barcelona, ES)

Abstract Slides Video

Presentation thumbnail

Short-pulse of systemic steroids in acute pericarditis: an alternative in refractory cases

Doctor A. Sanchez Arjona (Majadahonda, ES)

Abstract Slides Video

Presentation thumbnail

Increased adoption of IL-1 pathway inhibition and the steroid-sparing paradigm shift: temporal trends in recurrent pericarditis treatment from the RESONANCE patient registry

Doctor P. Cremer (Chicago, US)

Abstract Slides Video

Presentation thumbnail

Multi-year recurrent pericarditis disease duration in Italian patients: clinical outcomes after cessation of long-term IL-1 pathway inhibition provide insights for chronic management

Doctor M. Imazio (Udine, IT)

Abstract Slides Video

Access the full session

Session thumbnail

Acute and chronic pericarditis: how to best manage your patients

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

You may be interested in

Congress Presentation

Addressing recurrent pericarditis: assessing patient and professional education needs

Congress Presentation

Whole exome sequencing in patients with recurrent pericarditis

Congress Presentation

Real-life experience with rilonacept for the treatment of recurrent pericarditis

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources